Effects of gabaculine, a new potent inhibitor of gamma-amonobutyrate transaminase, on the brain gamma-amonobutyrate content and convulsions in mice.
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors*; D000613:Aminobutyrates / Q000032:analysis*; D000818:Animals; D000927:Anticonvulsants; D001923:Brain Chemistry / Q000187:drug effects*; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology*; D003510:Cyclohexanes / Q000008:administration & dosage; D003514:Cyclohexylamines / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004597:Electroshock; D007274:Injections, Intraperitoneal; D007276:Injections, Intraventricular; D008297:Male; D051379:Mice; D010852:Picrotoxin; D012663:Semicarbazides; D013997:Time Factors; D000637:Transaminases / Q000037:antagonists & inhibitors*; D005680:gamma-Aminobutyric Acid / Q000032:analysis*
D000612:4-Aminobutyrate Transaminase; D000613:Aminobutyrates; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D003510:Cyclohexanes; D003514:Cyclohexylamines; D010852:Picrotoxin; D012663:Semicarbazides; D000637:Transaminases; D005680:gamma-Aminobutyric Acid; C012987:gabaculine